RBC
LLY icon

Roble Belko & Company’s Eli Lilly LLY Stock Holding History

Roble Belko & Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Hold
416
– – 0.05% 90
2026
Q1 		$383K Buy
416
+399
+2,347% +$405K 0.05% 91
2025
Q4 		$18K Hold
17
– – ﹤0.01% 270
2025
Q3 		$13K Buy
17
+15
+750% +$11.2K ﹤0.01% 259
2025
Q2 		$2K Buy
+2
New +$1.55K ﹤0.01% 338
2022
Q2 		– Sell
-30
Closed -$9K – 356
2022
Q1 		$9K Buy
+30
New +$7.72K ﹤0.01% 294
2016
Q1 		– Sell
-151
Closed -$13K – 265
2015
Q4 		$13K Buy
+151
New +$12.5K 0.01% 138

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Roble Belko & Company's LLY Position: Q2 2026 in Review

Roble Belko & Company held its Eli Lilly (LLY) position steady in Q2 2026 at 416 shares worth $499K. The position accounts for 0.05% of the portfolio, ranked #90.

Roble Belko & Company first reported a position in LLY in Q4 2015 and has held it in 7 quarters since. 1,591 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Roble Belko & Company held 416 shares of Eli Lilly worth $499K as of Q2 2026.
  • Roble Belko & Company left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.05% of Roble Belko & Company's portfolio in Q2 2026, its #90 holding.
  • Roble Belko & Company first reported a position in Eli Lilly in Q4 2015 and has held it in 7 quarters since.
  • 1,591 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.